LifeVantage Corp
LFVN
查看详细走势图
6.200USD
-0.060-0.96%
收盘 12/19, 16:00（美东）报价延迟15分钟
78.68M总市值
7.52市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-0.96%
5天
-4.62%
1月
-3.58%
6月
-50.52%
今年开始到现在
-64.63%
1年
-64.29%
查看详细走势图
TradingKey LifeVantage Corp股票评分
单位: USD 更新时间: 2025-12-19操作建议
LifeVantage Corp当前公司基本面数据相对健康，增长潜力很大。当前估值合理，在药品行业排名65/158位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价14.50。中期看，股价处于下降通道。近一个月，市场表现一般，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
LifeVantage Corp评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
2
位分析师
买入
评级
14.500
目标均价
+119.36%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
LifeVantage Corp亮点
亮点风险
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
利润高增长
公司净利润处于行业前列，最新年度总收入228.53M美元
高分红
公司属于高分红公司，最新股息支付率21.08%
估值低估
公司最新PE估值7.52，处于3年历史低位
机构加仓
最新机构持股9.12M股，环比增加9.47%
PRFDX持仓
明星投资者PRFDX持仓，最新持仓市值9.30K
活跃度降低
近期活跃度降低，过去20天平均换手率-0.15
LifeVantage Corp新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
LifeVantage Corp简介
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
公司代码LFVN
公司LifeVantage Corp
CEOFife (Steven R)
网址https://www.lifevantage.com/
常见问题
LifeVantage Corp(LFVN)的当前股价是多少？
LifeVantage Corp(LFVN)的当前股价是 6.200。
LifeVantage Corp的股票代码是什么？
LifeVantage Corp的股票代码是LFVN。
LifeVantage Corp股票的52周最高点是多少？
LifeVantage Corp股票的52周最高点是27.380。
LifeVantage Corp股票的52周最低点是多少？
LifeVantage Corp股票的52周最低点是5.690。
LifeVantage Corp的市值是多少？
LifeVantage Corp的市值是78.68M。
LifeVantage Corp的净利润是多少？
LifeVantage Corp的净利润为9.80M。
现在LifeVantage Corp(LFVN)的股票是买入、持有还是卖出？
根据分析师评级，LifeVantage Corp(LFVN)的总体评级为买入，目标价格为14.500。
LifeVantage Corp(LFVN)股票的每股收益（EPS TTM）是多少
LifeVantage Corp(LFVN)股票的每股收益（EPS TTM）是0.824。
相关品种
